Program details
-
Keynote lecture 1
Chair(s): Moon-Kyu Lee
Friday 16 October, 11:20~12:00
Room 1
-
It’s a new world of medicine as we explore how targeting the Nutrient Simulating Hormones (NuSHs) has transformed our ability to manage the chronic diseases that are the public health challenge of the 21st century. But is this a case of “More tears are shed over answered prayers”? In this lecture, Prof. Donna Ryan will explore the promise and precautions of the remarkable biologic advances that gave us powerful medications targeting GLP-1 and GIP Receptors.
-
-
KL1-L1
Donna RyanPennington Biomedical Research Center, USA
-
Answered prayers: the GLP-1 RA related medications provide efficacy beyond appetite and incretin effects
-
Keynote lecture 2
Chair(s): In-Kyu Lee
Saturday 17 October, 11:10~11:50
Room 1
-
Globally about 65% of adults with type 2 diabetes have metabolic dysfunction-associated steatotic liver disease (MASLD) and among adults with type 2 diabetes who underwent liver biopsy 65% have metabolic dysfunction-associated steatohepatitis (MASH). The close link between MASLD and type 2 diabetes is explained by shared pathogenesis and mutual influence. In this lecture important novel findings about the heterogeneity of MASLD with respect to its pathogenesis, outcomes, and metabolism-based treatment responses is being presented.
-
-
KL2-L1
Norbert StefanUniversity Tübingen, Germany
-
MASLD: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment
